{"gene":"ABCC2","run_date":"2026-06-09T22:02:36","timeline":{"discoveries":[{"year":1996,"finding":"ABCC2 (cMrp) was cloned from rat liver as a canalicular membrane glycoprotein of ~190 kDa that mediates ATP-dependent transport of glutathione and glucuronate conjugates from hepatocytes into bile; it was absent from the canalicular membrane of two hyperbilirubinemic mutant rat strains (Eisai hyperbilirubinemic rat and GY/TR-), which are deficient in ATP-dependent conjugate transport across the canalicular membrane.","method":"cDNA cloning, immunoblotting, double immunofluorescence and confocal laser scanning microscopy, comparison with transport-deficient mutant rats","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — molecular cloning combined with direct localization (confocal microscopy), functional loss-of-function in two independent mutant rat strains, replicated across multiple methods in one study","pmids":["8662992"],"is_preprint":false},{"year":1996,"finding":"Human cMOAT (ABCC2) was overexpressed in cisplatin-resistant cancer cell lines and was associated with decreased drug accumulation, identifying ABCC2 as a potential cisplatin efflux transporter; its chromosomal locus was mapped to 10q24 by FISH.","method":"RT-PCR/Northern blot, FISH, comparison of cisplatin-resistant vs. sensitive cell lines","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — correlation of overexpression with cisplatin resistance in multiple cell lines, but no direct transport reconstitution; replicated across multiple cell lines","pmids":["8797578"],"is_preprint":false},{"year":1998,"finding":"ABCC2 (cMOAT) expressed in polarized MDCK cells localizes to the apical plasma membrane and mediates ATP-dependent transport of glutathione conjugates (S-(2,4-dinitrophenyl)-glutathione, glutathione conjugate of ethacrynic acid, S-(PGA1)-glutathione) and the anticancer drug vinblastine to the apical side; in non-polarized cells cMOAT was predominantly intracellular, indicating that a polarized cellular context is required for correct plasma membrane routing.","method":"cDNA transfection in polarized MDCK cells, transport assays across cell monolayers, immunofluorescence localization","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — functional transport reconstitution in polarized cells with multiple substrates, direct localization, inhibitor controls; single lab but multiple orthogonal methods","pmids":["9525973"],"is_preprint":false},{"year":1998,"finding":"Mutations (two deletions and a missense mutation in the ATP-binding-cassette/active transport signature region) in the cMOAT gene were identified in patients with Dubin-Johnson syndrome, demonstrating that loss-of-function mutations in ABCC2 are the molecular basis of this hereditary conjugated hyperbilirubinemia.","method":"Mutation analysis of genomic DNA from DJS patients, sequencing","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct sequencing of disease-causing mutations in human patients, consistent with concurrent animal model data; replicated across independent cohorts","pmids":["9425227"],"is_preprint":false},{"year":1999,"finding":"The human MRP2/cMOAT gene contains 32 exons with a structure conserved with other ABC genes; all DJS-causing mutations identified cluster in the cytoplasmic domain containing the two ATP-binding cassettes and linker region, with particular concentration in the first ATP-binding cassette domain, indicating this region is critical for transport function.","method":"Genomic sequencing, exon-intron structure determination, mutation characterization in DJS patients","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — comprehensive genomic characterization with disease-linked mutation mapping; single lab, direct sequencing","pmids":["10053008"],"is_preprint":false},{"year":1999,"finding":"PDZK1, a PDZ domain-containing protein, interacts with the carboxy-terminal portion of ABCC2 (cMOAT), as demonstrated by yeast two-hybrid assay, suggesting a scaffolding/clustering role for ABCC2 at the membrane.","method":"Yeast two-hybrid assay","journal":"Laboratory investigation","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single yeast two-hybrid assay, no validation by Co-IP or pulldown in mammalian cells","pmids":["10496535"],"is_preprint":false},{"year":2001,"finding":"ABCC2 (MRP2) transcription is regulated by the nuclear receptors PXR, CAR, and FXR, which bind as heterodimers with RXRα to an everted repeat (ER-8) element 440 bp upstream of the transcription start site; mutation of this element abolished nuclear receptor responsiveness, and induction by PXR agonists was absent in PXR-null mice.","method":"Luciferase reporter assays, gel-shift and supershift assays, primary hepatocyte treatments, PXR-null mouse experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (reporter assay, EMSA, mutagenesis, PXR-null mice) in one study with rigorous controls","pmids":["11706036"],"is_preprint":false},{"year":2002,"finding":"The Dubin-Johnson syndrome mutation I1173F in ABCC2 causes the mutant protein to be retained predominantly in the endoplasmic reticulum as a core-glycosylated form, degraded by proteasomes, and unable to mediate ATP-dependent transport of leukotriene C4; in polarized HepG2 cells, GFP-tagged MRP2-I1173F was found at the apical membrane in only 5% of cells compared with 80% for wild-type MRP2.","method":"Stable transfection in HEK-293 cells, vesicular transport assays, immunofluorescence in HepG2 cells, Western blotting (glycosylation), proteasome inhibitor experiments","journal":"American journal of physiology. Gastrointestinal and liver physiology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (transport assay, glycosylation analysis, proteasome inhibition, localization) in one study demonstrating mechanism of loss-of-function","pmids":["12388192"],"is_preprint":false},{"year":2004,"finding":"Genipin enhances ABCC2 (Mrp2)-mediated bile formation by stimulating exocytosis and insertion of Mrp2 protein into the canalicular membrane, increasing protein density in the canalicular membrane without altering mRNA levels; this was absent in Mrp2-deficient rats, confirming Mrp2 dependence.","method":"Rat infusion experiments, biliary secretion assays, ATP-dependent uptake in canalicular membrane vesicles, immunoelectron microscopy, Western blotting, compared in Mrp2-deficient rats","journal":"Hepatology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (in vivo biliary secretion, in vitro vesicular transport, immunoelectron microscopy, Mrp2-null controls) in one study","pmids":["14752835"],"is_preprint":false},{"year":2005,"finding":"A heterozygous ABCC2 mutation (R412G) in the cytoplasmic part of the second membrane-spanning domain was associated with impaired methotrexate elimination; functional analysis in transiently transfected CHO cells showed loss of transport activity for the G412 MRP2 mutant protein.","method":"Patient sequencing, functional analysis in transiently transfected CHO cells, pharmacokinetic measurement of methotrexate","journal":"Pharmacogenetics and genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro functional assay in transfected cells combined with clinical pharmacokinetic data; single lab, two orthogonal methods","pmids":["15864128"],"is_preprint":false},{"year":2006,"finding":"Nrf2 regulates ABCC2 (Mrp2) gene expression through binding to antioxidant response elements (ARE) in the Mrp2 promoter, preferentially the proximal ARE-1 element (-95 to -85); Nrf2 knockdown by siRNA suppressed tBHQ-induced ABCC2 mRNA induction, and Nrf2 overexpression increased ARE-1-mediated reporter activity, whereas dominant-negative Nrf2 repressed it.","method":"Gel-shift and supershift assays, promoter deletion analysis, CAT reporter assays, siRNA knockdown, BHA treatment of mice and hepatoma cells","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (EMSA, deletion analysis, Nrf2 siRNA, overexpression/dominant-negative) in one study establishing the ARE-Nrf2 mechanism","pmids":["16426233"],"is_preprint":false},{"year":2006,"finding":"ABCC2 is exclusively localized to the apical membrane domain of polarized cells (hepatocytes, renal proximal tubule epithelia, intestinal epithelia) and mediates unidirectional efflux of glutathione, glucuronate, and sulfate conjugates including leukotriene C4 and bilirubin glucuronosides; hereditary deficiency (Dubin-Johnson syndrome) results in compensatory upregulation of basolateral ABCC3.","method":"Review synthesizing prior experimental data (immunolocalization, transport assays, knockout/mutant animals, patient studies)","journal":"Pflugers Archiv","confidence":"Medium","confidence_rationale":"Tier 2 / Strong — review synthesizing multiple prior experimental studies; no new primary data but strong cross-study replication","pmids":["16847695"],"is_preprint":false},{"year":2007,"finding":"ABCC2 (MRP2) transports quercetin glucuronides in a position-dependent manner; computational 3D modeling predicted that the 4'-O-β-D-glucuronide interacts most strongly and 3-O-β-D-glucuronide most weakly with ABCC2, which was confirmed experimentally using binding and competition assays on ABCC2-overexpressing Sf9 cells; MK571 and cyclosporin A inhibited export of quercetin glucuronides from Caco-2 cells.","method":"In silico 3D homology modeling, competition assays with ABCC2-overexpressing Sf9 membrane vesicles, transport inhibition assays in Caco-2 cells","journal":"Drug metabolism and disposition","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — computational prediction validated by two orthogonal experimental approaches; single lab","pmids":["17478601"],"is_preprint":false},{"year":2008,"finding":"Abcc2 is the primary transporter responsible for biliary excretion of methotrexate (MTX) and its toxic metabolite 7-hydroxymethotrexate (7OH-MTX); in Abcc2-knockout mice, biliary excretion of MTX was 3.7-fold reduced, and in the absence of Abcc2, Abcc3 compensates by transporting MTX/7OH-MTX back into the circulation from the liver, leading to increased plasma levels and urinary excretion.","method":"Abcc2(-/-) and Abcc2;Abcc3(-/-) double knockout mouse pharmacokinetic studies, plasma AUC, biliary and urinary excretion measurements","journal":"Clinical cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout combined with pharmacokinetic analysis in multiple knockout combinations, rigorous in vivo epistasis","pmids":["19088030"],"is_preprint":false},{"year":2009,"finding":"Abcc2 is responsible for almost all hepatobiliary excretion of etoposide; in Abcc2-deficient mice, loss of biliary etoposide excretion is compensated by increased hepatic formation of etoposide glucuronide secreted via Abcc3 into blood; Abcc2;Abcc3 double-knockout mice showed high hepatic accumulation of etoposide glucuronide, demonstrating that Abcc2 and Abcc3 provide alternative pathways for hepatic elimination of etoposide glucuronide.","method":"Abcb1a/1b(-/-), Abcc2(-/-), Abcc3(-/-), double/triple knockout mouse pharmacokinetic studies","journal":"Clinical cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo epistasis using multiple knockout mouse strains with rigorous pharmacokinetic measurement","pmids":["20028753"],"is_preprint":false},{"year":2011,"finding":"Abcc2 deficiency in mice was associated with a significant increase in erythromycin metabolism (without changes in Cyp3a expression or activity), indicating that impaired ABCC2 biliary excretion enhances hepatic exposure and thus metabolism of erythromycin; homozygosity for the reduced-function ABCC2 variant rs717620 in humans was also linked to increased erythromycin metabolism.","method":"Abcc2 knockout mouse studies, Cyp3a activity assays, human cohort genotyping and erythromycin breath test","journal":"Clinical pharmacology and therapeutics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockout mouse plus human pharmacokinetic data; mechanistic interpretation (enhanced exposure → enhanced metabolism) supported by Cyp3a controls","pmids":["21451505"],"is_preprint":false},{"year":2013,"finding":"Ezrin phosphorylation status regulates MRP2/ABCC2 membrane localization along the intestinal tract; expression of a dephosphorylated ezrin mutant (T567A) in Caco-2 cells decreased both membrane surface-localized and total MRP2/ABCC2 expression, while conventional PKC isoforms regulate ezrin phosphorylation; phosphorylated ezrin co-distributes with Mrp2 along the rat gastrointestinal tract.","method":"Wild-type and T567A ezrin mutant expression in Caco-2 cells, immunofluorescence, Western blotting, in vivo rat tissue expression profiling","journal":"American journal of physiology. Gastrointestinal and liver physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — site-directed mutagenesis of ezrin with functional consequence on ABCC2 localization/expression; single lab, two orthogonal methods (in vitro mutagenesis + in vivo expression profiling)","pmids":["24091598"],"is_preprint":false},{"year":2015,"finding":"In human obstructive cholestasis, PKCα, δ, and ε are upregulated and stimulate phosphorylation of Ezrin at Thr567 (not Radixin), which drives MRP2 internalization from the canalicular membrane; ubiquitin ligase E3 GP78 mediates subsequent proteasomal degradation of internalized MRP2; Ezrin (not Radixin) co-immunoprecipitates with MRP2 in human livers, and increased phospho-Ezrin Thr567 correlates with increased co-precipitated MRP2 in cholestatic livers.","method":"Immunoprecipitation, Western blotting, Co-IP, PKC overexpression/inhibition in HepG2 cells, liver biopsies from cholestatic patients (n=30) vs. controls (n=23)","journal":"Journal of hepatology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — reciprocal co-IP establishing Ezrin-MRP2 interaction, PKC overexpression with functional consequence on MRP2 membrane expression, identification of GP78 as E3 ligase, validated in human tissue; multiple orthogonal methods","pmids":["26212029"],"is_preprint":false},{"year":2017,"finding":"In vitro functional analysis of seven ABCC2 SNPs expressed in Flp-In HEK293 cells showed that the C2366T variant reduced MRP2 cell surface expression by 40-50% and reduced vesicular CDCF transport by 50%; the G1249A variant had decreased vesicular CDCF transport without altered surface expression; G3542T, T3563A, C3972T, and G4544A variants enhanced calcein AM efflux despite similar surface expression compared to wild type.","method":"Site-directed mutagenesis, stable expression in HEK293 cells, flow cytometry of surface expression, substrate accumulation assays, inverted membrane vesicle transport assays","journal":"Pharmaceutical research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro functional reconstitution with mutagenesis of multiple variants, both cell-based and vesicular assays; single lab but multiple orthogonal methods","pmids":["28405913"],"is_preprint":false},{"year":2020,"finding":"ISG15 suppresses ABCC2 protein expression in cisplatin-resistant ovarian cancer cells by ISGylating hnRNPA2B1, which normally binds the 5'UTR of ABCC2 mRNA to promote its translation; ISGylation blocks hnRNPA2B1 recruitment to ABCC2 mRNA, thereby suppressing ABCC2 translation; overexpression of wild-type (but not ISGylation-deficient) ISG15 reduced ABCC2 protein and sensitized cells to cisplatin, while ABCC2 overexpression blocked this sensitization.","method":"Overexpression of WT and mutant ISG15, RNA immunoprecipitation, Western blotting, cell viability assays, ABCC2 overexpression rescue experiments","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (RNA-IP, mutagenesis, rescue experiment) in single lab establishing ISGylation-mediated translational repression of ABCC2","pmids":["31926942"],"is_preprint":false},{"year":2003,"finding":"ABCC2 (TR- rat model) mediates biliary transport of 4-glutathionylcyclophosphamide (GSCY); in ABCC2-deficient TR- rats, GSCY was absent from bile, and liver exposure to HCY and its metabolites was significantly increased, demonstrating that ABCC2 is required for biliary elimination of this glutathione conjugate of cyclophosphamide.","method":"Comparison of ABCC2-deficient TR- rats and wild-type Wistar rats after CY administration, biliary collection and quantification of GSCY, liver and plasma AUC measurements","journal":"The Journal of pharmacology and experimental therapeutics","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo loss-of-function in ABCC2-deficient rats with pharmacokinetic measurements of biliary excretion; rigorous genetic controls","pmids":["14617693"],"is_preprint":false},{"year":2006,"finding":"In freshly isolated rat hepatocytes, Mrp2 is confined to junctions between adjacent cells, intracellular compartments, and 'legacy' canalicular structures, not the basolateral membrane; functional accumulation of the Mrp2 substrate CDF in cellular compartments was sensitive to the MRP inhibitor MK571 and absent in hepatocytes from Mrp2-deficient rats, confirming functional Mrp2 activity in isolated hepatocytes despite loss of macroscopic canalicular polarity.","method":"Immunostaining and confocal microscopy of isolated rat hepatocytes, functional CDF accumulation assay, MK571 inhibition, Mrp2-deficient rat controls","journal":"Drug metabolism and disposition","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization combined with functional assay using genetic control (Mrp2-null rats); single lab","pmids":["17954525"],"is_preprint":false},{"year":1998,"finding":"Rat cMOAT (ABCC2) expressed in polarized MDCK cells is functionally localized to the apical membrane and mediates preferential apical export of glutathione S-bimane (GS-B); this preferential apical export was inhibited by cyclosporin A.","method":"cDNA transfection in MDCK cells, GS-B export measurement from apical and basal compartments, cyclosporin A inhibition","journal":"Pharmaceutical research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional transport assay in polarized cell system with inhibitor control; single lab, single method","pmids":["9892468"],"is_preprint":false},{"year":2019,"finding":"Alternative polyadenylation of ABCC2 mRNA produces 3'-UTR length variants; short ABCC2 3'-UTR variants lack the miR-379 binding site, and expression of these short variants in luciferase reporter assays leads to loss of miR-379/ABCC2 interaction and significant upregulation of ABCC2 expression, representing a posttranscriptional regulatory mechanism.","method":"3'-RACE, luciferase reporter gene assays in vitro, tissue expression analysis","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro reporter assays directly demonstrating miR-379/ABCC2 3'-UTR interaction loss; single lab","pmids":["31757862"],"is_preprint":false}],"current_model":"ABCC2 (MRP2/cMOAT) is an ATP-binding cassette transporter that localizes exclusively to the apical/canalicular membrane of polarized cells (hepatocytes, renal proximal tubule, enterocytes) via a polarization-dependent trafficking pathway regulated by ezrin phosphorylation and PKC signaling, where it functions as a primary-active export pump for glutathione, glucuronate, and sulfate conjugates (including bilirubin glucuronosides, leukotriene C4, and numerous drug conjugates); its transcription is induced by nuclear receptors PXR, CAR, and FXR through a shared ER-8 response element and by Nrf2 through proximal ARE elements, while its translation is post-transcriptionally suppressed by ISGylation-mediated inhibition of hnRNPA2B1; loss-of-function mutations clustering in the first ATP-binding cassette domain cause Dubin-Johnson syndrome by preventing correct protein maturation, membrane targeting, and transport activity, with compensatory upregulation of basolateral ABCC3 in the liver."},"narrative":{"mechanistic_narrative":"ABCC2 (MRP2/cMOAT) is an ATP-binding cassette transporter that functions as a primary-active export pump at the apical/canalicular membrane of polarized epithelia, driving unidirectional efflux of glutathione, glucuronate, and sulfate conjugates—including bilirubin glucuronosides, leukotriene C4, and a broad range of drug conjugates—from hepatocytes, renal tubule, and intestinal cells [PMID:8662992, PMID:9525973, PMID:16847695]. Its canalicular function was established by its absence in transport-deficient hyperbilirubinemic mutant rats and by reconstituted apical conjugate transport in polarized MDCK cells, which also revealed that a polarized cellular context is required for correct plasma-membrane routing [PMID:8662992, PMID:9525973, PMID:9892468]. In vivo loss-of-function studies define ABCC2 as the principal route for biliary elimination of conjugated and cytotoxic compounds—glutathionyl-cyclophosphamide, methotrexate and 7-hydroxymethotrexate, and etoposide—where its absence is buffered by basolateral ABCC3, which redirects substrates back to the circulation [PMID:19088030, PMID:20028753, PMID:14617693]. Apical residence is dynamically controlled by ezrin: PKC-driven phosphorylation of ezrin at Thr567 governs MRP2 membrane insertion versus internalization, with internalized protein degraded via the E3 ligase GP78, a pathway activated in cholestasis [PMID:24091598, PMID:26212029]. Transcription is induced by the nuclear receptors PXR, CAR, and FXR through a shared upstream ER-8 element and by Nrf2 through proximal antioxidant response elements, while post-transcriptional control operates through alternative polyadenylation/miR-379 and through ISGylation of hnRNPA2B1 that suppresses ABCC2 translation [PMID:11706036, PMID:16426233, PMID:31926942, PMID:31757862]. Loss-of-function mutations clustering in the cytoplasmic ATP-binding cassette region cause Dubin-Johnson syndrome by impairing protein maturation, apical targeting, and transport activity [PMID:9425227, PMID:10053008, PMID:12388192].","teleology":[{"year":1996,"claim":"Established the molecular identity of the canalicular conjugate export pump by cloning ABCC2 and tying it to the defect in hyperbilirubinemic mutant rats, answering what protein mediates ATP-dependent biliary excretion of conjugates.","evidence":"cDNA cloning, immunoblotting, confocal immunofluorescence, and comparison with two transport-deficient mutant rat strains","pmids":["8662992"],"confidence":"High","gaps":["Substrate range defined only for glutathione/glucuronate conjugates","Transport mechanism not reconstituted in a defined system"]},{"year":1996,"claim":"Linked ABCC2 overexpression to cisplatin resistance and mapped the locus, introducing a role in cancer drug efflux.","evidence":"RT-PCR/Northern blot and FISH comparing cisplatin-resistant vs sensitive cancer cell lines","pmids":["8797578"],"confidence":"Medium","gaps":["No direct transport reconstitution for cisplatin","Correlation does not establish causal efflux"]},{"year":1998,"claim":"Demonstrated that ABCC2 requires a polarized cellular context for apical membrane routing and directly transports glutathione conjugates and vinblastine, answering where it acts and what it carries.","evidence":"cDNA transfection in polarized MDCK cells with transbilayer transport assays, immunofluorescence, and inhibitor controls","pmids":["9525973","9892468"],"confidence":"High","gaps":["Trafficking determinants for polarized routing not identified","MDCK is a heterologous epithelial model"]},{"year":1998,"claim":"Identified ABCC2 loss-of-function mutations as the molecular cause of Dubin-Johnson syndrome, connecting the transporter to human disease.","evidence":"Sequencing of genomic DNA from DJS patients identifying deletions and a missense mutation in the ABC signature region","pmids":["9425227"],"confidence":"High","gaps":["Mechanism by which mutations abolish function not yet defined in this study"]},{"year":1999,"claim":"Defined gene structure and showed DJS mutations cluster in the cytoplasmic ATP-binding cassette region, localizing the functionally critical domain.","evidence":"Genomic exon-intron determination and mutation mapping in DJS patients","pmids":["10053008"],"confidence":"Medium","gaps":["No structural model of the ATP-binding domain","Single lab characterization"]},{"year":1999,"claim":"Proposed a scaffolding interaction by detecting PDZK1 binding to the ABCC2 C-terminus.","evidence":"Yeast two-hybrid assay","pmids":["10496535"],"confidence":"Low","gaps":["Single yeast two-hybrid without Co-IP or pulldown validation","Functional consequence of the interaction untested"]},{"year":2001,"claim":"Established nuclear-receptor transcriptional control of ABCC2 via a shared ER-8 element, explaining drug- and bile-acid-mediated induction.","evidence":"Luciferase reporters, EMSA/supershift, promoter mutagenesis, primary hepatocytes, and PXR-null mice","pmids":["11706036"],"confidence":"High","gaps":["Relative contribution of PXR/CAR/FXR in vivo not partitioned","Coactivator requirements unaddressed"]},{"year":2002,"claim":"Defined the cellular mechanism of a DJS mutation, showing I1173F causes ER retention, proteasomal degradation, and loss of apical targeting and transport.","evidence":"Stable transfection, vesicular transport assays, glycosylation analysis, proteasome inhibition, and HepG2 localization","pmids":["12388192"],"confidence":"High","gaps":["Generality across other DJS mutations not tested here","Chaperone/quality-control machinery not identified"]},{"year":2003,"claim":"Demonstrated ABCC2 is required for biliary elimination of a glutathione-conjugated chemotherapeutic, extending its substrate scope to cyclophosphamide metabolites.","evidence":"Biliary and tissue pharmacokinetics in ABCC2-deficient TR- vs wild-type rats","pmids":["14617693"],"confidence":"High","gaps":["Kinetic parameters of transport not determined"]},{"year":2004,"claim":"Showed ABCC2 canalicular density is acutely regulated by exocytic insertion, establishing trafficking as a control point for bile formation.","evidence":"Rat infusion, biliary secretion, canalicular membrane vesicle uptake, immunoelectron microscopy, with Mrp2-deficient controls","pmids":["14752835"],"confidence":"High","gaps":["Signaling pathway driving genipin-induced exocytosis not defined"]},{"year":2005,"claim":"Linked an ABCC2 variant to impaired drug elimination, connecting genetic variation to pharmacokinetics.","evidence":"Patient sequencing, transfected CHO functional assay, and methotrexate pharmacokinetics","pmids":["15864128"],"confidence":"Medium","gaps":["Single variant, single lab","Mechanism of activity loss not resolved"]},{"year":2006,"claim":"Established Nrf2/ARE-driven transcriptional induction of ABCC2, linking it to the oxidative stress response.","evidence":"EMSA, promoter deletion, CAT reporters, Nrf2 siRNA, and dominant-negative experiments in mice and hepatoma cells","pmids":["16426233"],"confidence":"High","gaps":["Interplay between Nrf2 and nuclear-receptor inputs not addressed"]},{"year":2006,"claim":"Consolidated the apical-exclusive localization across tissues and the compensatory ABCC3 upregulation in deficiency.","evidence":"Review synthesizing immunolocalization, transport, mutant-animal, and patient data","pmids":["16847695"],"confidence":"Medium","gaps":["No new primary data","Compensation mechanism not mechanistically dissected"]},{"year":2007,"claim":"Showed substrate handling is regioselective using quercetin glucuronides, refining substrate recognition.","evidence":"In silico homology modeling validated by competition assays in Sf9 vesicles and inhibition in Caco-2 cells","pmids":["17478601"],"confidence":"Medium","gaps":["Binding-site model not experimentally confirmed structurally"]},{"year":2008,"claim":"Defined ABCC2/ABCC3 epistasis in methotrexate disposition, showing ABCC3 reroutes substrate to circulation when ABCC2 is lost.","evidence":"Pharmacokinetics in Abcc2 and Abcc2;Abcc3 double-knockout mice","pmids":["19088030"],"confidence":"High","gaps":["Human relevance of compensation magnitude not quantified"]},{"year":2009,"claim":"Extended the ABCC2/ABCC3 alternative-elimination model to etoposide and its glucuronide.","evidence":"Pharmacokinetics across single, double, and triple knockout mouse strains","pmids":["20028753"],"confidence":"High","gaps":["Tissue-specific contributions beyond liver not parsed"]},{"year":2011,"claim":"Connected ABCC2 biliary excretion to downstream drug metabolism, showing deficiency raises hepatic exposure and metabolism of erythromycin.","evidence":"Abcc2 knockout mice with Cyp3a controls and human cohort genotyping with breath test","pmids":["21451505"],"confidence":"Medium","gaps":["Indirect mechanism inferred","Human variant effect modest"]},{"year":2013,"claim":"Identified ezrin phosphorylation as a determinant of MRP2 membrane localization, linking cytoskeletal adaptors to apical residence.","evidence":"Ezrin T567A mutant expression in Caco-2 cells with immunofluorescence/Western and in vivo rat tissue profiling","pmids":["24091598"],"confidence":"Medium","gaps":["Direct ezrin-MRP2 binding not shown in this study","PKC isoform specificity unresolved here"]},{"year":2015,"claim":"Established the cholestasis-driven internalization-degradation axis, showing PKC-phospho-Ezrin Thr567 drives MRP2 internalization and GP78 mediates its proteasomal degradation.","evidence":"Reciprocal Co-IP, PKC overexpression/inhibition in HepG2, and cholestatic vs control human liver biopsies","pmids":["26212029"],"confidence":"High","gaps":["Order of phosphorylation, internalization, and ubiquitination not kinetically resolved"]},{"year":2017,"claim":"Resolved functional consequences of multiple coding SNPs, distinguishing surface-expression defects from intrinsic transport changes.","evidence":"Site-directed mutagenesis, stable HEK293 expression, flow cytometry, substrate accumulation, and vesicle transport assays","pmids":["28405913"],"confidence":"High","gaps":["In vivo pharmacologic impact of each variant untested","Single lab"]},{"year":2019,"claim":"Revealed 3'-UTR alternative polyadenylation as a post-transcriptional switch via loss of miR-379 regulation.","evidence":"3'-RACE, luciferase reporter assays, and tissue expression analysis","pmids":["31757862"],"confidence":"Medium","gaps":["Physiological triggers of APA choice unknown","Reporter-based, single lab"]},{"year":2020,"claim":"Defined a translational repression mechanism in which ISGylation of hnRNPA2B1 blocks ABCC2 5'UTR binding, linking ABCC2 levels to cisplatin sensitivity.","evidence":"WT/mutant ISG15 overexpression, RNA-IP, Western blot, viability assays, and ABCC2 overexpression rescue","pmids":["31926942"],"confidence":"Medium","gaps":["Generality beyond ovarian cancer cells untested","Single lab"]},{"year":null,"claim":"How transcriptional, post-transcriptional, and trafficking control are integrated to set apical ABCC2 levels in different tissues, and the high-resolution structural basis of substrate recognition, remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No experimental atomic structure of human ABCC2 in the corpus","Cross-talk among PXR/CAR/FXR, Nrf2, miR-379, and ISGylation pathways not integrated","Mechanism of polarized apical sorting not molecularly defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0,2,7]},{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,2,13,20]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,2,11]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[7]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,2,13,20]},{"term_id":"R-HSA-9748784","term_label":"Drug ADME","supporting_discovery_ids":[13,14,15]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[6,10]}],"complexes":[],"partners":["EZR","GP78","PDZK1","HNRNPA2B1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q92887","full_name":"ATP-binding cassette sub-family C member 2","aliases":["Canalicular multidrug resistance protein","Canalicular multispecific organic anion transporter 1","Multidrug resistance-associated protein 2"],"length_aa":1545,"mass_kda":174.2,"function":"ATP-dependent transporter of the ATP-binding cassette (ABC) family that binds and hydrolyzes ATP to enable active transport of various substrates including many drugs, toxicants and endogenous compound across cell membranes. Transports a wide variety of conjugated organic anions such as sulfate-, glucuronide- and glutathione (GSH)-conjugates of endo- and xenobiotics substrates (PubMed:10220572, PubMed:10421658, PubMed:11500505, PubMed:16332456). Mediates hepatobiliary excretion of mono- and bis-glucuronidated bilirubin molecules and therefore play an important role in bilirubin detoxification (PubMed:10421658). Also mediates hepatobiliary excretion of others glucuronide conjugates such as 17beta-estradiol 17-glucosiduronic acid and leukotriene C4 (PubMed:11500505). Transports sulfated bile salt such as taurolithocholate sulfate (PubMed:16332456). Transports various anticancer drugs, such as anthracycline, vinca alkaloid and methotrexate and HIV-drugs such as protease inhibitors (PubMed:10220572, PubMed:11500505, PubMed:12441801). Confers resistance to several anti-cancer drugs including cisplatin, doxorubicin, epirubicin, methotrexate, etoposide and vincristine (PubMed:10220572, PubMed:11500505)","subcellular_location":"Apical cell membrane","url":"https://www.uniprot.org/uniprotkb/Q92887/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ABCC2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ABCC2","total_profiled":1310},"omim":[{"mim_id":"619874","title":"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 11; PFIC11","url":"https://www.omim.org/entry/619874"},{"mim_id":"619662","title":"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 8; PFIC8","url":"https://www.omim.org/entry/619662"},{"mim_id":"617008","title":"CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3","url":"https://www.omim.org/entry/617008"},{"mim_id":"615520","title":"MICRO RNA 297; MIR297","url":"https://www.omim.org/entry/615520"},{"mim_id":"612505","title":"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 8; ABCA8","url":"https://www.omim.org/entry/612505"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"intestine","ntpm":37.9},{"tissue":"liver","ntpm":113.8}],"url":"https://www.proteinatlas.org/search/ABCC2"},"hgnc":{"alias_symbol":["DJS","MRP2","cMRP"],"prev_symbol":["CMOAT"]},"alphafold":{"accession":"Q92887","domains":[{"cath_id":"-","chopping":"2-206","consensus_level":"medium","plddt":81.7758,"start":2,"end":206},{"cath_id":"1.20.1560.10","chopping":"461-554_956-1120","consensus_level":"medium","plddt":88.0445,"start":461,"end":1120},{"cath_id":"3.40.50.300","chopping":"628-864","consensus_level":"medium","plddt":84.2968,"start":628,"end":864},{"cath_id":"3.40.50.300","chopping":"1301-1379_1459-1471_1490-1536","consensus_level":"high","plddt":85.4965,"start":1301,"end":1536}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92887","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q92887-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q92887-F1-predicted_aligned_error_v6.png","plddt_mean":81.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ABCC2","jax_strain_url":"https://www.jax.org/strain/search?query=ABCC2"},"sequence":{"accession":"Q92887","fasta_url":"https://rest.uniprot.org/uniprotkb/Q92887.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q92887/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92887"}},"corpus_meta":[{"pmid":"9270026","id":"PMC_9270026","title":"Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.","date":"1997","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9270026","citation_count":792,"is_preprint":false},{"pmid":"11706036","id":"PMC_11706036","title":"Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11706036","citation_count":727,"is_preprint":false},{"pmid":"8662992","id":"PMC_8662992","title":"cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8662992","citation_count":533,"is_preprint":false},{"pmid":"8797578","id":"PMC_8797578","title":"A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation.","date":"1996","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8797578","citation_count":437,"is_preprint":false},{"pmid":"9525973","id":"PMC_9525973","title":"Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.","date":"1998","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/9525973","citation_count":423,"is_preprint":false},{"pmid":"16847695","id":"PMC_16847695","title":"The apical conjugate efflux pump ABCC2 (MRP2).","date":"2006","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16847695","citation_count":270,"is_preprint":false},{"pmid":"9407953","id":"PMC_9407953","title":"A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells.","date":"1997","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9407953","citation_count":236,"is_preprint":false},{"pmid":"9212074","id":"PMC_9212074","title":"Hepatic canalicular membrane 5: Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver.","date":"1997","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/9212074","citation_count":216,"is_preprint":false},{"pmid":"9425227","id":"PMC_9425227","title":"Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome.","date":"1998","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9425227","citation_count":206,"is_preprint":false},{"pmid":"16426233","id":"PMC_16426233","title":"Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16426233","citation_count":190,"is_preprint":false},{"pmid":"10053008","id":"PMC_10053008","title":"Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome.","date":"1999","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10053008","citation_count":187,"is_preprint":false},{"pmid":"16863439","id":"PMC_16863439","title":"Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition.","date":"2006","source":"Expert opinion on drug metabolism & toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/16863439","citation_count":183,"is_preprint":false},{"pmid":"12406647","id":"PMC_12406647","title":"Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition.","date":"2002","source":"Advanced drug delivery reviews","url":"https://pubmed.ncbi.nlm.nih.gov/12406647","citation_count":183,"is_preprint":false},{"pmid":"17083032","id":"PMC_17083032","title":"Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy.","date":"2006","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/17083032","citation_count":177,"is_preprint":false},{"pmid":"17534875","id":"PMC_17534875","title":"Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer.","date":"2007","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17534875","citation_count":169,"is_preprint":false},{"pmid":"9827529","id":"PMC_9827529","title":"Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins.","date":"1998","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/9827529","citation_count":132,"is_preprint":false},{"pmid":"25154974","id":"PMC_25154974","title":"Mis-splicing of the ABCC2 gene linked with Bt toxin resistance in Helicoverpa armigera.","date":"2014","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25154974","citation_count":130,"is_preprint":false},{"pmid":"9875554","id":"PMC_9875554","title":"Excretion of GSSG and glutathione conjugates mediated by MRP1 and cMOAT/MRP2.","date":"1998","source":"Seminars in liver disease","url":"https://pubmed.ncbi.nlm.nih.gov/9875554","citation_count":126,"is_preprint":false},{"pmid":"10496535","id":"PMC_10496535","title":"PDZK1, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome 1q21, interacts with cMOAT (MRP2), the multidrug resistance-associated protein.","date":"1999","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/10496535","citation_count":123,"is_preprint":false},{"pmid":"15821043","id":"PMC_15821043","title":"Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation.","date":"2005","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/15821043","citation_count":116,"is_preprint":false},{"pmid":"25162314","id":"PMC_25162314","title":"Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.","date":"2014","source":"Expert opinion on drug metabolism & toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/25162314","citation_count":113,"is_preprint":false},{"pmid":"15864128","id":"PMC_15864128","title":"A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination.","date":"2005","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/15864128","citation_count":113,"is_preprint":false},{"pmid":"12839578","id":"PMC_12839578","title":"Overexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin.","date":"2003","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/12839578","citation_count":109,"is_preprint":false},{"pmid":"17172311","id":"PMC_17172311","title":"Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors.","date":"2006","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/17172311","citation_count":109,"is_preprint":false},{"pmid":"14752835","id":"PMC_14752835","title":"Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver.","date":"2004","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/14752835","citation_count":95,"is_preprint":false},{"pmid":"12065434","id":"PMC_12065434","title":"Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1.","date":"2002","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/12065434","citation_count":94,"is_preprint":false},{"pmid":"12388192","id":"PMC_12388192","title":"A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2).","date":"2002","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12388192","citation_count":91,"is_preprint":false},{"pmid":"16513445","id":"PMC_16513445","title":"Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans.","date":"2006","source":"Clinical pharmacology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/16513445","citation_count":89,"is_preprint":false},{"pmid":"17954525","id":"PMC_17954525","title":"Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in freshly isolated rat hepatocytes.","date":"2007","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/17954525","citation_count":85,"is_preprint":false},{"pmid":"17145840","id":"PMC_17145840","title":"ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome.","date":"2006","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/17145840","citation_count":82,"is_preprint":false},{"pmid":"18038766","id":"PMC_18038766","title":"Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress.","date":"2007","source":"Journal of experimental therapeutics & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/18038766","citation_count":80,"is_preprint":false},{"pmid":"18334920","id":"PMC_18334920","title":"Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol.","date":"2008","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/18334920","citation_count":80,"is_preprint":false},{"pmid":"20028753","id":"PMC_20028753","title":"P-glycoprotein (P-gp/Abcb1), Abcc2, and Abcc3 determine the pharmacokinetics of etoposide.","date":"2009","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/20028753","citation_count":77,"is_preprint":false},{"pmid":"17997497","id":"PMC_17997497","title":"Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy.","date":"2007","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/17997497","citation_count":76,"is_preprint":false},{"pmid":"11901101","id":"PMC_11901101","title":"Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).","date":"2002","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/11901101","citation_count":73,"is_preprint":false},{"pmid":"9441949","id":"PMC_9441949","title":"Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?","date":"1997","source":"Seminars in cancer biology","url":"https://pubmed.ncbi.nlm.nih.gov/9441949","citation_count":72,"is_preprint":false},{"pmid":"17478601","id":"PMC_17478601","title":"Interaction of positional isomers of quercetin glucuronides with the transporter ABCC2 (cMOAT, MRP2).","date":"2007","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/17478601","citation_count":71,"is_preprint":false},{"pmid":"20351751","id":"PMC_20351751","title":"Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function.","date":"2010","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/20351751","citation_count":69,"is_preprint":false},{"pmid":"9381978","id":"PMC_9381978","title":"The canalicular multidrug resistance protein, cMRP/MRP2, a novel conjugate export pump expressed in the apical membrane of hepatocytes.","date":"1997","source":"Advances in enzyme regulation","url":"https://pubmed.ncbi.nlm.nih.gov/9381978","citation_count":67,"is_preprint":false},{"pmid":"22112610","id":"PMC_22112610","title":"Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.","date":"2011","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22112610","citation_count":64,"is_preprint":false},{"pmid":"10427140","id":"PMC_10427140","title":"Overexpression of multidrug resistance genes MDR1 and cMOAT in human hepatocellular carcinoma and hepatoblastoma cell lines.","date":"1999","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/10427140","citation_count":63,"is_preprint":false},{"pmid":"33459081","id":"PMC_33459081","title":"ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?","date":"2021","source":"Expert opinion on drug metabolism & toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/33459081","citation_count":59,"is_preprint":false},{"pmid":"21266201","id":"PMC_21266201","title":"Molecular characterization and functions of zebrafish ABCC2 in cellular efflux of heavy metals.","date":"2011","source":"Comparative biochemistry and physiology. Toxicology & pharmacology : CBP","url":"https://pubmed.ncbi.nlm.nih.gov/21266201","citation_count":59,"is_preprint":false},{"pmid":"9569044","id":"PMC_9569044","title":"Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs.","date":"1998","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9569044","citation_count":58,"is_preprint":false},{"pmid":"16213010","id":"PMC_16213010","title":"MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma.","date":"2005","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/16213010","citation_count":56,"is_preprint":false},{"pmid":"19008001","id":"PMC_19008001","title":"Cloning and molecular characterization of apical efflux transporters (ABCB1, ABCB11 and ABCC2) in rainbow trout (Oncorhynchus mykiss) hepatocytes.","date":"2008","source":"Aquatic toxicology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/19008001","citation_count":56,"is_preprint":false},{"pmid":"19088030","id":"PMC_19088030","title":"Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the in vivo elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate.","date":"2008","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/19088030","citation_count":54,"is_preprint":false},{"pmid":"26212029","id":"PMC_26212029","title":"Canalicular membrane MRP2/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasis.","date":"2015","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/26212029","citation_count":51,"is_preprint":false},{"pmid":"14636316","id":"PMC_14636316","title":"Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR- rats.","date":"2003","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/14636316","citation_count":51,"is_preprint":false},{"pmid":"25380746","id":"PMC_25380746","title":"New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition.","date":"2014","source":"Expert opinion on drug metabolism & toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/25380746","citation_count":50,"is_preprint":false},{"pmid":"18926681","id":"PMC_18926681","title":"Polymorphisms of MRP2 (ABCC2) are associated with susceptibility to nonalcoholic fatty liver disease.","date":"2008","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18926681","citation_count":50,"is_preprint":false},{"pmid":"31759051","id":"PMC_31759051","title":"MicroRNA-998-3p contributes to Cry1Ac-resistance by targeting ABCC2 in lepidopteran insects.","date":"2019","source":"Insect biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31759051","citation_count":48,"is_preprint":false},{"pmid":"28539590","id":"PMC_28539590","title":"ABCC2 is associated with Bacillus thuringiensis Cry1Ac toxin oligomerization and membrane insertion in diamondback moth.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28539590","citation_count":48,"is_preprint":false},{"pmid":"26557010","id":"PMC_26557010","title":"Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.","date":"2015","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/26557010","citation_count":48,"is_preprint":false},{"pmid":"16876126","id":"PMC_16876126","title":"RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16876126","citation_count":47,"is_preprint":false},{"pmid":"21566011","id":"PMC_21566011","title":"Impact of abcc2 [multidrug resistance-associated protein (MRP) 2], abcc3 (MRP3), and abcg2 (breast cancer resistance protein) on the oral pharmacokinetics of methotrexate and its main metabolite 7-hydroxymethotrexate.","date":"2011","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/21566011","citation_count":46,"is_preprint":false},{"pmid":"16434545","id":"PMC_16434545","title":"Altered hepatobiliary disposition of 5 (and 6)-carboxy-2',7'-dichlorofluorescein in Abcg2 (Bcrp1) and Abcc2 (Mrp2) knockout mice.","date":"2006","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/16434545","citation_count":45,"is_preprint":false},{"pmid":"32290427","id":"PMC_32290427","title":"CRISPR-Mediated Knockout of the ABCC2 Gene in Ostrinia furnacalis Confers High-Level Resistance to the Bacillus thuringiensis Cry1Fa Toxin.","date":"2020","source":"Toxins","url":"https://pubmed.ncbi.nlm.nih.gov/32290427","citation_count":45,"is_preprint":false},{"pmid":"17156953","id":"PMC_17156953","title":"Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug efflux.","date":"2006","source":"International journal of pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/17156953","citation_count":45,"is_preprint":false},{"pmid":"20943283","id":"PMC_20943283","title":"Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients.","date":"2010","source":"Lung cancer (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/20943283","citation_count":44,"is_preprint":false},{"pmid":"27914919","id":"PMC_27914919","title":"Expressing a moth abcc2 gene in transgenic Drosophila causes susceptibility to Bt Cry1Ac without requiring a cadherin-like protein receptor.","date":"2016","source":"Insect biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27914919","citation_count":44,"is_preprint":false},{"pmid":"32815556","id":"PMC_32815556","title":"Increased ABCC2 expression predicts cisplatin resistance in non-small cell lung cancer.","date":"2020","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/32815556","citation_count":43,"is_preprint":false},{"pmid":"9398612","id":"PMC_9398612","title":"Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells.","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9398612","citation_count":43,"is_preprint":false},{"pmid":"10377250","id":"PMC_10377250","title":"Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5-trichlorophenoxyacetic acid in the mouse liver.","date":"1999","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10377250","citation_count":42,"is_preprint":false},{"pmid":"25155934","id":"PMC_25155934","title":"Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.","date":"2014","source":"Pharmacogenomics","url":"https://pubmed.ncbi.nlm.nih.gov/25155934","citation_count":40,"is_preprint":false},{"pmid":"21449672","id":"PMC_21449672","title":"Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsy.","date":"2011","source":"Pharmacogenomics","url":"https://pubmed.ncbi.nlm.nih.gov/21449672","citation_count":39,"is_preprint":false},{"pmid":"25823783","id":"PMC_25823783","title":"SCN1A, ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxcarbazepine therapy.","date":"2015","source":"Pharmacogenomics","url":"https://pubmed.ncbi.nlm.nih.gov/25823783","citation_count":38,"is_preprint":false},{"pmid":"21674030","id":"PMC_21674030","title":"Strain- and sex-dependent circadian changes in abcc2 transporter expression: implications for irinotecan chronotolerance in mouse ileum.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21674030","citation_count":37,"is_preprint":false},{"pmid":"28736301","id":"PMC_28736301","title":"FOXA transcriptional factor modulates insect susceptibility to Bacillus thuringiensis Cry1Ac toxin by regulating the expression of toxin-receptor ABCC2 and ABCC3 genes.","date":"2017","source":"Insect biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28736301","citation_count":37,"is_preprint":false},{"pmid":"8869738","id":"PMC_8869738","title":"The function of the multidrug resistance proteins (MRP and cMRP) in drug conjugate transport and hepatobiliary excretion.","date":"1996","source":"Advances in enzyme regulation","url":"https://pubmed.ncbi.nlm.nih.gov/8869738","citation_count":36,"is_preprint":false},{"pmid":"25801567","id":"PMC_25801567","title":"Influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patients.","date":"2015","source":"Antimicrobial agents and chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/25801567","citation_count":36,"is_preprint":false},{"pmid":"21986666","id":"PMC_21986666","title":"ABCC2 (MRP2, cMOAT) localized in the nuclear envelope of breast carcinoma cells correlates with poor clinical outcome.","date":"2011","source":"Pathology oncology research : POR","url":"https://pubmed.ncbi.nlm.nih.gov/21986666","citation_count":35,"is_preprint":false},{"pmid":"22664480","id":"PMC_22664480","title":"Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression.","date":"2012","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/22664480","citation_count":35,"is_preprint":false},{"pmid":"27590272","id":"PMC_27590272","title":"Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.","date":"2016","source":"Chinese journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27590272","citation_count":35,"is_preprint":false},{"pmid":"16542205","id":"PMC_16542205","title":"Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms.","date":"2006","source":"British journal of clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16542205","citation_count":33,"is_preprint":false},{"pmid":"31544333","id":"PMC_31544333","title":"Genetic contribution of ABCC2 to Dubin-Johnson syndrome and inherited cholestatic disorders.","date":"2019","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/31544333","citation_count":32,"is_preprint":false},{"pmid":"31926942","id":"PMC_31926942","title":"ISG15 suppresses translation of ABCC2 via ISGylation of hnRNPA2B1 and enhances drug sensitivity in cisplatin resistant ovarian cancer cells.","date":"2020","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/31926942","citation_count":32,"is_preprint":false},{"pmid":"22186618","id":"PMC_22186618","title":"Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy.","date":"2011","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/22186618","citation_count":31,"is_preprint":false},{"pmid":"26189305","id":"PMC_26189305","title":"ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population.","date":"2015","source":"Die Pharmazie","url":"https://pubmed.ncbi.nlm.nih.gov/26189305","citation_count":30,"is_preprint":false},{"pmid":"22256867","id":"PMC_22256867","title":"Lack of association between ABCC2 gene variants and treatment response in epilepsy.","date":"2012","source":"Pharmacogenomics","url":"https://pubmed.ncbi.nlm.nih.gov/22256867","citation_count":29,"is_preprint":false},{"pmid":"21451505","id":"PMC_21451505","title":"Effect of ABCC2 (MRP2) transport function on erythromycin metabolism.","date":"2011","source":"Clinical pharmacology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/21451505","citation_count":29,"is_preprint":false},{"pmid":"27816260","id":"PMC_27816260","title":"The ABCC2 c.-24C>T polymorphism increases the risk of resistance to antiepileptic drugs: A meta-analysis.","date":"2016","source":"Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia","url":"https://pubmed.ncbi.nlm.nih.gov/27816260","citation_count":28,"is_preprint":false},{"pmid":"22534871","id":"PMC_22534871","title":"Associations between ABCC2 polymorphisms and cisplatin disposition and efficacy.","date":"2012","source":"Clinical pharmacology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/22534871","citation_count":28,"is_preprint":false},{"pmid":"28961159","id":"PMC_28961159","title":"In Vitro Assessment of the Effect of Antiepileptic Drugs on Expression and Function of ABC Transporters and Their Interactions with ABCC2.","date":"2017","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/28961159","citation_count":28,"is_preprint":false},{"pmid":"16377077","id":"PMC_16377077","title":"Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response.","date":"2005","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/16377077","citation_count":26,"is_preprint":false},{"pmid":"33519779","id":"PMC_33519779","title":"Genomic Insights Into the Antifungal Activity and Plant Growth-Promoting Ability in Bacillus velezensis CMRP 4490.","date":"2021","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/33519779","citation_count":25,"is_preprint":false},{"pmid":"28554132","id":"PMC_28554132","title":"The human RNA surveillance factor Up-frameshift 1 inhibits hepatic cancer progression by targeting MRP2/ABCC2.","date":"2017","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/28554132","citation_count":25,"is_preprint":false},{"pmid":"31354331","id":"PMC_31354331","title":"Effects of MTHFR and ABCC2 gene polymorphisms on antiepileptic drug responsiveness in Jordanian epileptic patients.","date":"2019","source":"Pharmacogenomics and personalized medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31354331","citation_count":24,"is_preprint":false},{"pmid":"31870219","id":"PMC_31870219","title":"Association of ABCC2 with levels and toxicity of methotrexate in Malaysian Childhood Acute Lymphoblastic Leukemia (ALL).","date":"2019","source":"Pediatric hematology and oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31870219","citation_count":24,"is_preprint":false},{"pmid":"9892468","id":"PMC_9892468","title":"Transfected rat cMOAT is functionally expressed on the apical membrane in Madin-Darby canine kidney (MDCK) cells.","date":"1998","source":"Pharmaceutical research","url":"https://pubmed.ncbi.nlm.nih.gov/9892468","citation_count":24,"is_preprint":false},{"pmid":"24325761","id":"PMC_24325761","title":"The effects of ABCC2 G1249A polymorphism on the risk of resistance to antiepileptic drugs: a meta-analysis of the literature.","date":"2013","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/24325761","citation_count":24,"is_preprint":false},{"pmid":"14617693","id":"PMC_14617693","title":"ABCC2-mediated biliary transport of 4-glutathionylcyclophosphamide and its contribution to elimination of 4-hydroxycyclophosphamide in rat.","date":"2003","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/14617693","citation_count":24,"is_preprint":false},{"pmid":"26390406","id":"PMC_26390406","title":"Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental passage of zidovudine.","date":"2016","source":"Biopharmaceutics & drug disposition","url":"https://pubmed.ncbi.nlm.nih.gov/26390406","citation_count":24,"is_preprint":false},{"pmid":"35510797","id":"PMC_35510797","title":"Sec24C mediates a Golgi-independent trafficking pathway that is required for tonoplast localisation of ABCC1 and ABCC2.","date":"2022","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/35510797","citation_count":23,"is_preprint":false},{"pmid":"30344695","id":"PMC_30344695","title":"Mutation analysis of the ABCC2 gene in Chinese patients with Dubin-Johnson syndrome.","date":"2018","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30344695","citation_count":19,"is_preprint":false},{"pmid":"24091598","id":"PMC_24091598","title":"Ezrin regulates the expression of Mrp2/Abcc2 and Mdr1/Abcb1 along the rat small intestinal tract.","date":"2013","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24091598","citation_count":19,"is_preprint":false},{"pmid":"31757862","id":"PMC_31757862","title":"Alternative Polyadenylation of ABC Transporters of the C-Family (ABCC1, ABCC2, ABCC3) and Implications on Posttranscriptional Micro-RNA Regulation.","date":"2019","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31757862","citation_count":19,"is_preprint":false},{"pmid":"23315030","id":"PMC_23315030","title":"Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPA.","date":"2013","source":"Investigational new drugs","url":"https://pubmed.ncbi.nlm.nih.gov/23315030","citation_count":19,"is_preprint":false},{"pmid":"28405913","id":"PMC_28405913","title":"In Vitro Transport Activity and Trafficking of MRP2/ABCC2 Polymorphic Variants.","date":"2017","source":"Pharmaceutical research","url":"https://pubmed.ncbi.nlm.nih.gov/28405913","citation_count":18,"is_preprint":false},{"pmid":"34055641","id":"PMC_34055641","title":"Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34055641","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":56516,"output_tokens":6464,"usd":0.133254,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15430,"output_tokens":5427,"usd":0.106412,"stage2_stop_reason":"end_turn"},"total_usd":0.239666,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"ABCC2 (cMrp) was cloned from rat liver as a canalicular membrane glycoprotein of ~190 kDa that mediates ATP-dependent transport of glutathione and glucuronate conjugates from hepatocytes into bile; it was absent from the canalicular membrane of two hyperbilirubinemic mutant rat strains (Eisai hyperbilirubinemic rat and GY/TR-), which are deficient in ATP-dependent conjugate transport across the canalicular membrane.\",\n      \"method\": \"cDNA cloning, immunoblotting, double immunofluorescence and confocal laser scanning microscopy, comparison with transport-deficient mutant rats\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — molecular cloning combined with direct localization (confocal microscopy), functional loss-of-function in two independent mutant rat strains, replicated across multiple methods in one study\",\n      \"pmids\": [\"8662992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Human cMOAT (ABCC2) was overexpressed in cisplatin-resistant cancer cell lines and was associated with decreased drug accumulation, identifying ABCC2 as a potential cisplatin efflux transporter; its chromosomal locus was mapped to 10q24 by FISH.\",\n      \"method\": \"RT-PCR/Northern blot, FISH, comparison of cisplatin-resistant vs. sensitive cell lines\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — correlation of overexpression with cisplatin resistance in multiple cell lines, but no direct transport reconstitution; replicated across multiple cell lines\",\n      \"pmids\": [\"8797578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"ABCC2 (cMOAT) expressed in polarized MDCK cells localizes to the apical plasma membrane and mediates ATP-dependent transport of glutathione conjugates (S-(2,4-dinitrophenyl)-glutathione, glutathione conjugate of ethacrynic acid, S-(PGA1)-glutathione) and the anticancer drug vinblastine to the apical side; in non-polarized cells cMOAT was predominantly intracellular, indicating that a polarized cellular context is required for correct plasma membrane routing.\",\n      \"method\": \"cDNA transfection in polarized MDCK cells, transport assays across cell monolayers, immunofluorescence localization\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — functional transport reconstitution in polarized cells with multiple substrates, direct localization, inhibitor controls; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"9525973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Mutations (two deletions and a missense mutation in the ATP-binding-cassette/active transport signature region) in the cMOAT gene were identified in patients with Dubin-Johnson syndrome, demonstrating that loss-of-function mutations in ABCC2 are the molecular basis of this hereditary conjugated hyperbilirubinemia.\",\n      \"method\": \"Mutation analysis of genomic DNA from DJS patients, sequencing\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct sequencing of disease-causing mutations in human patients, consistent with concurrent animal model data; replicated across independent cohorts\",\n      \"pmids\": [\"9425227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The human MRP2/cMOAT gene contains 32 exons with a structure conserved with other ABC genes; all DJS-causing mutations identified cluster in the cytoplasmic domain containing the two ATP-binding cassettes and linker region, with particular concentration in the first ATP-binding cassette domain, indicating this region is critical for transport function.\",\n      \"method\": \"Genomic sequencing, exon-intron structure determination, mutation characterization in DJS patients\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — comprehensive genomic characterization with disease-linked mutation mapping; single lab, direct sequencing\",\n      \"pmids\": [\"10053008\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"PDZK1, a PDZ domain-containing protein, interacts with the carboxy-terminal portion of ABCC2 (cMOAT), as demonstrated by yeast two-hybrid assay, suggesting a scaffolding/clustering role for ABCC2 at the membrane.\",\n      \"method\": \"Yeast two-hybrid assay\",\n      \"journal\": \"Laboratory investigation\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single yeast two-hybrid assay, no validation by Co-IP or pulldown in mammalian cells\",\n      \"pmids\": [\"10496535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"ABCC2 (MRP2) transcription is regulated by the nuclear receptors PXR, CAR, and FXR, which bind as heterodimers with RXRα to an everted repeat (ER-8) element 440 bp upstream of the transcription start site; mutation of this element abolished nuclear receptor responsiveness, and induction by PXR agonists was absent in PXR-null mice.\",\n      \"method\": \"Luciferase reporter assays, gel-shift and supershift assays, primary hepatocyte treatments, PXR-null mouse experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (reporter assay, EMSA, mutagenesis, PXR-null mice) in one study with rigorous controls\",\n      \"pmids\": [\"11706036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The Dubin-Johnson syndrome mutation I1173F in ABCC2 causes the mutant protein to be retained predominantly in the endoplasmic reticulum as a core-glycosylated form, degraded by proteasomes, and unable to mediate ATP-dependent transport of leukotriene C4; in polarized HepG2 cells, GFP-tagged MRP2-I1173F was found at the apical membrane in only 5% of cells compared with 80% for wild-type MRP2.\",\n      \"method\": \"Stable transfection in HEK-293 cells, vesicular transport assays, immunofluorescence in HepG2 cells, Western blotting (glycosylation), proteasome inhibitor experiments\",\n      \"journal\": \"American journal of physiology. Gastrointestinal and liver physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (transport assay, glycosylation analysis, proteasome inhibition, localization) in one study demonstrating mechanism of loss-of-function\",\n      \"pmids\": [\"12388192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Genipin enhances ABCC2 (Mrp2)-mediated bile formation by stimulating exocytosis and insertion of Mrp2 protein into the canalicular membrane, increasing protein density in the canalicular membrane without altering mRNA levels; this was absent in Mrp2-deficient rats, confirming Mrp2 dependence.\",\n      \"method\": \"Rat infusion experiments, biliary secretion assays, ATP-dependent uptake in canalicular membrane vesicles, immunoelectron microscopy, Western blotting, compared in Mrp2-deficient rats\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (in vivo biliary secretion, in vitro vesicular transport, immunoelectron microscopy, Mrp2-null controls) in one study\",\n      \"pmids\": [\"14752835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"A heterozygous ABCC2 mutation (R412G) in the cytoplasmic part of the second membrane-spanning domain was associated with impaired methotrexate elimination; functional analysis in transiently transfected CHO cells showed loss of transport activity for the G412 MRP2 mutant protein.\",\n      \"method\": \"Patient sequencing, functional analysis in transiently transfected CHO cells, pharmacokinetic measurement of methotrexate\",\n      \"journal\": \"Pharmacogenetics and genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro functional assay in transfected cells combined with clinical pharmacokinetic data; single lab, two orthogonal methods\",\n      \"pmids\": [\"15864128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Nrf2 regulates ABCC2 (Mrp2) gene expression through binding to antioxidant response elements (ARE) in the Mrp2 promoter, preferentially the proximal ARE-1 element (-95 to -85); Nrf2 knockdown by siRNA suppressed tBHQ-induced ABCC2 mRNA induction, and Nrf2 overexpression increased ARE-1-mediated reporter activity, whereas dominant-negative Nrf2 repressed it.\",\n      \"method\": \"Gel-shift and supershift assays, promoter deletion analysis, CAT reporter assays, siRNA knockdown, BHA treatment of mice and hepatoma cells\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (EMSA, deletion analysis, Nrf2 siRNA, overexpression/dominant-negative) in one study establishing the ARE-Nrf2 mechanism\",\n      \"pmids\": [\"16426233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ABCC2 is exclusively localized to the apical membrane domain of polarized cells (hepatocytes, renal proximal tubule epithelia, intestinal epithelia) and mediates unidirectional efflux of glutathione, glucuronate, and sulfate conjugates including leukotriene C4 and bilirubin glucuronosides; hereditary deficiency (Dubin-Johnson syndrome) results in compensatory upregulation of basolateral ABCC3.\",\n      \"method\": \"Review synthesizing prior experimental data (immunolocalization, transport assays, knockout/mutant animals, patient studies)\",\n      \"journal\": \"Pflugers Archiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Strong — review synthesizing multiple prior experimental studies; no new primary data but strong cross-study replication\",\n      \"pmids\": [\"16847695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ABCC2 (MRP2) transports quercetin glucuronides in a position-dependent manner; computational 3D modeling predicted that the 4'-O-β-D-glucuronide interacts most strongly and 3-O-β-D-glucuronide most weakly with ABCC2, which was confirmed experimentally using binding and competition assays on ABCC2-overexpressing Sf9 cells; MK571 and cyclosporin A inhibited export of quercetin glucuronides from Caco-2 cells.\",\n      \"method\": \"In silico 3D homology modeling, competition assays with ABCC2-overexpressing Sf9 membrane vesicles, transport inhibition assays in Caco-2 cells\",\n      \"journal\": \"Drug metabolism and disposition\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — computational prediction validated by two orthogonal experimental approaches; single lab\",\n      \"pmids\": [\"17478601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Abcc2 is the primary transporter responsible for biliary excretion of methotrexate (MTX) and its toxic metabolite 7-hydroxymethotrexate (7OH-MTX); in Abcc2-knockout mice, biliary excretion of MTX was 3.7-fold reduced, and in the absence of Abcc2, Abcc3 compensates by transporting MTX/7OH-MTX back into the circulation from the liver, leading to increased plasma levels and urinary excretion.\",\n      \"method\": \"Abcc2(-/-) and Abcc2;Abcc3(-/-) double knockout mouse pharmacokinetic studies, plasma AUC, biliary and urinary excretion measurements\",\n      \"journal\": \"Clinical cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout combined with pharmacokinetic analysis in multiple knockout combinations, rigorous in vivo epistasis\",\n      \"pmids\": [\"19088030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Abcc2 is responsible for almost all hepatobiliary excretion of etoposide; in Abcc2-deficient mice, loss of biliary etoposide excretion is compensated by increased hepatic formation of etoposide glucuronide secreted via Abcc3 into blood; Abcc2;Abcc3 double-knockout mice showed high hepatic accumulation of etoposide glucuronide, demonstrating that Abcc2 and Abcc3 provide alternative pathways for hepatic elimination of etoposide glucuronide.\",\n      \"method\": \"Abcb1a/1b(-/-), Abcc2(-/-), Abcc3(-/-), double/triple knockout mouse pharmacokinetic studies\",\n      \"journal\": \"Clinical cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo epistasis using multiple knockout mouse strains with rigorous pharmacokinetic measurement\",\n      \"pmids\": [\"20028753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Abcc2 deficiency in mice was associated with a significant increase in erythromycin metabolism (without changes in Cyp3a expression or activity), indicating that impaired ABCC2 biliary excretion enhances hepatic exposure and thus metabolism of erythromycin; homozygosity for the reduced-function ABCC2 variant rs717620 in humans was also linked to increased erythromycin metabolism.\",\n      \"method\": \"Abcc2 knockout mouse studies, Cyp3a activity assays, human cohort genotyping and erythromycin breath test\",\n      \"journal\": \"Clinical pharmacology and therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockout mouse plus human pharmacokinetic data; mechanistic interpretation (enhanced exposure → enhanced metabolism) supported by Cyp3a controls\",\n      \"pmids\": [\"21451505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Ezrin phosphorylation status regulates MRP2/ABCC2 membrane localization along the intestinal tract; expression of a dephosphorylated ezrin mutant (T567A) in Caco-2 cells decreased both membrane surface-localized and total MRP2/ABCC2 expression, while conventional PKC isoforms regulate ezrin phosphorylation; phosphorylated ezrin co-distributes with Mrp2 along the rat gastrointestinal tract.\",\n      \"method\": \"Wild-type and T567A ezrin mutant expression in Caco-2 cells, immunofluorescence, Western blotting, in vivo rat tissue expression profiling\",\n      \"journal\": \"American journal of physiology. Gastrointestinal and liver physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — site-directed mutagenesis of ezrin with functional consequence on ABCC2 localization/expression; single lab, two orthogonal methods (in vitro mutagenesis + in vivo expression profiling)\",\n      \"pmids\": [\"24091598\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In human obstructive cholestasis, PKCα, δ, and ε are upregulated and stimulate phosphorylation of Ezrin at Thr567 (not Radixin), which drives MRP2 internalization from the canalicular membrane; ubiquitin ligase E3 GP78 mediates subsequent proteasomal degradation of internalized MRP2; Ezrin (not Radixin) co-immunoprecipitates with MRP2 in human livers, and increased phospho-Ezrin Thr567 correlates with increased co-precipitated MRP2 in cholestatic livers.\",\n      \"method\": \"Immunoprecipitation, Western blotting, Co-IP, PKC overexpression/inhibition in HepG2 cells, liver biopsies from cholestatic patients (n=30) vs. controls (n=23)\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — reciprocal co-IP establishing Ezrin-MRP2 interaction, PKC overexpression with functional consequence on MRP2 membrane expression, identification of GP78 as E3 ligase, validated in human tissue; multiple orthogonal methods\",\n      \"pmids\": [\"26212029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In vitro functional analysis of seven ABCC2 SNPs expressed in Flp-In HEK293 cells showed that the C2366T variant reduced MRP2 cell surface expression by 40-50% and reduced vesicular CDCF transport by 50%; the G1249A variant had decreased vesicular CDCF transport without altered surface expression; G3542T, T3563A, C3972T, and G4544A variants enhanced calcein AM efflux despite similar surface expression compared to wild type.\",\n      \"method\": \"Site-directed mutagenesis, stable expression in HEK293 cells, flow cytometry of surface expression, substrate accumulation assays, inverted membrane vesicle transport assays\",\n      \"journal\": \"Pharmaceutical research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro functional reconstitution with mutagenesis of multiple variants, both cell-based and vesicular assays; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"28405913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ISG15 suppresses ABCC2 protein expression in cisplatin-resistant ovarian cancer cells by ISGylating hnRNPA2B1, which normally binds the 5'UTR of ABCC2 mRNA to promote its translation; ISGylation blocks hnRNPA2B1 recruitment to ABCC2 mRNA, thereby suppressing ABCC2 translation; overexpression of wild-type (but not ISGylation-deficient) ISG15 reduced ABCC2 protein and sensitized cells to cisplatin, while ABCC2 overexpression blocked this sensitization.\",\n      \"method\": \"Overexpression of WT and mutant ISG15, RNA immunoprecipitation, Western blotting, cell viability assays, ABCC2 overexpression rescue experiments\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (RNA-IP, mutagenesis, rescue experiment) in single lab establishing ISGylation-mediated translational repression of ABCC2\",\n      \"pmids\": [\"31926942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ABCC2 (TR- rat model) mediates biliary transport of 4-glutathionylcyclophosphamide (GSCY); in ABCC2-deficient TR- rats, GSCY was absent from bile, and liver exposure to HCY and its metabolites was significantly increased, demonstrating that ABCC2 is required for biliary elimination of this glutathione conjugate of cyclophosphamide.\",\n      \"method\": \"Comparison of ABCC2-deficient TR- rats and wild-type Wistar rats after CY administration, biliary collection and quantification of GSCY, liver and plasma AUC measurements\",\n      \"journal\": \"The Journal of pharmacology and experimental therapeutics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo loss-of-function in ABCC2-deficient rats with pharmacokinetic measurements of biliary excretion; rigorous genetic controls\",\n      \"pmids\": [\"14617693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In freshly isolated rat hepatocytes, Mrp2 is confined to junctions between adjacent cells, intracellular compartments, and 'legacy' canalicular structures, not the basolateral membrane; functional accumulation of the Mrp2 substrate CDF in cellular compartments was sensitive to the MRP inhibitor MK571 and absent in hepatocytes from Mrp2-deficient rats, confirming functional Mrp2 activity in isolated hepatocytes despite loss of macroscopic canalicular polarity.\",\n      \"method\": \"Immunostaining and confocal microscopy of isolated rat hepatocytes, functional CDF accumulation assay, MK571 inhibition, Mrp2-deficient rat controls\",\n      \"journal\": \"Drug metabolism and disposition\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization combined with functional assay using genetic control (Mrp2-null rats); single lab\",\n      \"pmids\": [\"17954525\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Rat cMOAT (ABCC2) expressed in polarized MDCK cells is functionally localized to the apical membrane and mediates preferential apical export of glutathione S-bimane (GS-B); this preferential apical export was inhibited by cyclosporin A.\",\n      \"method\": \"cDNA transfection in MDCK cells, GS-B export measurement from apical and basal compartments, cyclosporin A inhibition\",\n      \"journal\": \"Pharmaceutical research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional transport assay in polarized cell system with inhibitor control; single lab, single method\",\n      \"pmids\": [\"9892468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Alternative polyadenylation of ABCC2 mRNA produces 3'-UTR length variants; short ABCC2 3'-UTR variants lack the miR-379 binding site, and expression of these short variants in luciferase reporter assays leads to loss of miR-379/ABCC2 interaction and significant upregulation of ABCC2 expression, representing a posttranscriptional regulatory mechanism.\",\n      \"method\": \"3'-RACE, luciferase reporter gene assays in vitro, tissue expression analysis\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro reporter assays directly demonstrating miR-379/ABCC2 3'-UTR interaction loss; single lab\",\n      \"pmids\": [\"31757862\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ABCC2 (MRP2/cMOAT) is an ATP-binding cassette transporter that localizes exclusively to the apical/canalicular membrane of polarized cells (hepatocytes, renal proximal tubule, enterocytes) via a polarization-dependent trafficking pathway regulated by ezrin phosphorylation and PKC signaling, where it functions as a primary-active export pump for glutathione, glucuronate, and sulfate conjugates (including bilirubin glucuronosides, leukotriene C4, and numerous drug conjugates); its transcription is induced by nuclear receptors PXR, CAR, and FXR through a shared ER-8 response element and by Nrf2 through proximal ARE elements, while its translation is post-transcriptionally suppressed by ISGylation-mediated inhibition of hnRNPA2B1; loss-of-function mutations clustering in the first ATP-binding cassette domain cause Dubin-Johnson syndrome by preventing correct protein maturation, membrane targeting, and transport activity, with compensatory upregulation of basolateral ABCC3 in the liver.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ABCC2 (MRP2/cMOAT) is an ATP-binding cassette transporter that functions as a primary-active export pump at the apical/canalicular membrane of polarized epithelia, driving unidirectional efflux of glutathione, glucuronate, and sulfate conjugates—including bilirubin glucuronosides, leukotriene C4, and a broad range of drug conjugates—from hepatocytes, renal tubule, and intestinal cells [#0, #2, #11]. Its canalicular function was established by its absence in transport-deficient hyperbilirubinemic mutant rats and by reconstituted apical conjugate transport in polarized MDCK cells, which also revealed that a polarized cellular context is required for correct plasma-membrane routing [#0, #2, #22]. In vivo loss-of-function studies define ABCC2 as the principal route for biliary elimination of conjugated and cytotoxic compounds—glutathionyl-cyclophosphamide, methotrexate and 7-hydroxymethotrexate, and etoposide—where its absence is buffered by basolateral ABCC3, which redirects substrates back to the circulation [#13, #14, #20]. Apical residence is dynamically controlled by ezrin: PKC-driven phosphorylation of ezrin at Thr567 governs MRP2 membrane insertion versus internalization, with internalized protein degraded via the E3 ligase GP78, a pathway activated in cholestasis [#16, #17]. Transcription is induced by the nuclear receptors PXR, CAR, and FXR through a shared upstream ER-8 element and by Nrf2 through proximal antioxidant response elements, while post-transcriptional control operates through alternative polyadenylation/miR-379 and through ISGylation of hnRNPA2B1 that suppresses ABCC2 translation [#6, #10, #19, #23]. Loss-of-function mutations clustering in the cytoplasmic ATP-binding cassette region cause Dubin-Johnson syndrome by impairing protein maturation, apical targeting, and transport activity [#3, #4, #7].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established the molecular identity of the canalicular conjugate export pump by cloning ABCC2 and tying it to the defect in hyperbilirubinemic mutant rats, answering what protein mediates ATP-dependent biliary excretion of conjugates.\",\n      \"evidence\": \"cDNA cloning, immunoblotting, confocal immunofluorescence, and comparison with two transport-deficient mutant rat strains\",\n      \"pmids\": [\"8662992\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Substrate range defined only for glutathione/glucuronate conjugates\", \"Transport mechanism not reconstituted in a defined system\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Linked ABCC2 overexpression to cisplatin resistance and mapped the locus, introducing a role in cancer drug efflux.\",\n      \"evidence\": \"RT-PCR/Northern blot and FISH comparing cisplatin-resistant vs sensitive cancer cell lines\",\n      \"pmids\": [\"8797578\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct transport reconstitution for cisplatin\", \"Correlation does not establish causal efflux\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrated that ABCC2 requires a polarized cellular context for apical membrane routing and directly transports glutathione conjugates and vinblastine, answering where it acts and what it carries.\",\n      \"evidence\": \"cDNA transfection in polarized MDCK cells with transbilayer transport assays, immunofluorescence, and inhibitor controls\",\n      \"pmids\": [\"9525973\", \"9892468\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trafficking determinants for polarized routing not identified\", \"MDCK is a heterologous epithelial model\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identified ABCC2 loss-of-function mutations as the molecular cause of Dubin-Johnson syndrome, connecting the transporter to human disease.\",\n      \"evidence\": \"Sequencing of genomic DNA from DJS patients identifying deletions and a missense mutation in the ABC signature region\",\n      \"pmids\": [\"9425227\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which mutations abolish function not yet defined in this study\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defined gene structure and showed DJS mutations cluster in the cytoplasmic ATP-binding cassette region, localizing the functionally critical domain.\",\n      \"evidence\": \"Genomic exon-intron determination and mutation mapping in DJS patients\",\n      \"pmids\": [\"10053008\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of the ATP-binding domain\", \"Single lab characterization\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Proposed a scaffolding interaction by detecting PDZK1 binding to the ABCC2 C-terminus.\",\n      \"evidence\": \"Yeast two-hybrid assay\",\n      \"pmids\": [\"10496535\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single yeast two-hybrid without Co-IP or pulldown validation\", \"Functional consequence of the interaction untested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Established nuclear-receptor transcriptional control of ABCC2 via a shared ER-8 element, explaining drug- and bile-acid-mediated induction.\",\n      \"evidence\": \"Luciferase reporters, EMSA/supershift, promoter mutagenesis, primary hepatocytes, and PXR-null mice\",\n      \"pmids\": [\"11706036\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of PXR/CAR/FXR in vivo not partitioned\", \"Coactivator requirements unaddressed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined the cellular mechanism of a DJS mutation, showing I1173F causes ER retention, proteasomal degradation, and loss of apical targeting and transport.\",\n      \"evidence\": \"Stable transfection, vesicular transport assays, glycosylation analysis, proteasome inhibition, and HepG2 localization\",\n      \"pmids\": [\"12388192\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality across other DJS mutations not tested here\", \"Chaperone/quality-control machinery not identified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrated ABCC2 is required for biliary elimination of a glutathione-conjugated chemotherapeutic, extending its substrate scope to cyclophosphamide metabolites.\",\n      \"evidence\": \"Biliary and tissue pharmacokinetics in ABCC2-deficient TR- vs wild-type rats\",\n      \"pmids\": [\"14617693\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinetic parameters of transport not determined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showed ABCC2 canalicular density is acutely regulated by exocytic insertion, establishing trafficking as a control point for bile formation.\",\n      \"evidence\": \"Rat infusion, biliary secretion, canalicular membrane vesicle uptake, immunoelectron microscopy, with Mrp2-deficient controls\",\n      \"pmids\": [\"14752835\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling pathway driving genipin-induced exocytosis not defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Linked an ABCC2 variant to impaired drug elimination, connecting genetic variation to pharmacokinetics.\",\n      \"evidence\": \"Patient sequencing, transfected CHO functional assay, and methotrexate pharmacokinetics\",\n      \"pmids\": [\"15864128\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single variant, single lab\", \"Mechanism of activity loss not resolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Established Nrf2/ARE-driven transcriptional induction of ABCC2, linking it to the oxidative stress response.\",\n      \"evidence\": \"EMSA, promoter deletion, CAT reporters, Nrf2 siRNA, and dominant-negative experiments in mice and hepatoma cells\",\n      \"pmids\": [\"16426233\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between Nrf2 and nuclear-receptor inputs not addressed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Consolidated the apical-exclusive localization across tissues and the compensatory ABCC3 upregulation in deficiency.\",\n      \"evidence\": \"Review synthesizing immunolocalization, transport, mutant-animal, and patient data\",\n      \"pmids\": [\"16847695\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No new primary data\", \"Compensation mechanism not mechanistically dissected\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed substrate handling is regioselective using quercetin glucuronides, refining substrate recognition.\",\n      \"evidence\": \"In silico homology modeling validated by competition assays in Sf9 vesicles and inhibition in Caco-2 cells\",\n      \"pmids\": [\"17478601\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Binding-site model not experimentally confirmed structurally\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined ABCC2/ABCC3 epistasis in methotrexate disposition, showing ABCC3 reroutes substrate to circulation when ABCC2 is lost.\",\n      \"evidence\": \"Pharmacokinetics in Abcc2 and Abcc2;Abcc3 double-knockout mice\",\n      \"pmids\": [\"19088030\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Human relevance of compensation magnitude not quantified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Extended the ABCC2/ABCC3 alternative-elimination model to etoposide and its glucuronide.\",\n      \"evidence\": \"Pharmacokinetics across single, double, and triple knockout mouse strains\",\n      \"pmids\": [\"20028753\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific contributions beyond liver not parsed\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Connected ABCC2 biliary excretion to downstream drug metabolism, showing deficiency raises hepatic exposure and metabolism of erythromycin.\",\n      \"evidence\": \"Abcc2 knockout mice with Cyp3a controls and human cohort genotyping with breath test\",\n      \"pmids\": [\"21451505\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Indirect mechanism inferred\", \"Human variant effect modest\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified ezrin phosphorylation as a determinant of MRP2 membrane localization, linking cytoskeletal adaptors to apical residence.\",\n      \"evidence\": \"Ezrin T567A mutant expression in Caco-2 cells with immunofluorescence/Western and in vivo rat tissue profiling\",\n      \"pmids\": [\"24091598\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ezrin-MRP2 binding not shown in this study\", \"PKC isoform specificity unresolved here\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Established the cholestasis-driven internalization-degradation axis, showing PKC-phospho-Ezrin Thr567 drives MRP2 internalization and GP78 mediates its proteasomal degradation.\",\n      \"evidence\": \"Reciprocal Co-IP, PKC overexpression/inhibition in HepG2, and cholestatic vs control human liver biopsies\",\n      \"pmids\": [\"26212029\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order of phosphorylation, internalization, and ubiquitination not kinetically resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Resolved functional consequences of multiple coding SNPs, distinguishing surface-expression defects from intrinsic transport changes.\",\n      \"evidence\": \"Site-directed mutagenesis, stable HEK293 expression, flow cytometry, substrate accumulation, and vesicle transport assays\",\n      \"pmids\": [\"28405913\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo pharmacologic impact of each variant untested\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Revealed 3'-UTR alternative polyadenylation as a post-transcriptional switch via loss of miR-379 regulation.\",\n      \"evidence\": \"3'-RACE, luciferase reporter assays, and tissue expression analysis\",\n      \"pmids\": [\"31757862\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological triggers of APA choice unknown\", \"Reporter-based, single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined a translational repression mechanism in which ISGylation of hnRNPA2B1 blocks ABCC2 5'UTR binding, linking ABCC2 levels to cisplatin sensitivity.\",\n      \"evidence\": \"WT/mutant ISG15 overexpression, RNA-IP, Western blot, viability assays, and ABCC2 overexpression rescue\",\n      \"pmids\": [\"31926942\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality beyond ovarian cancer cells untested\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How transcriptional, post-transcriptional, and trafficking control are integrated to set apical ABCC2 levels in different tissues, and the high-resolution structural basis of substrate recognition, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No experimental atomic structure of human ABCC2 in the corpus\", \"Cross-talk among PXR/CAR/FXR, Nrf2, miR-379, and ISGylation pathways not integrated\", \"Mechanism of polarized apical sorting not molecularly defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 2, 7]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 2, 13, 20]},\n      {\"term_id\": \"GO:0042626\", \"supporting_discovery_ids\": []}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 2, 11]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 2, 13, 20]},\n      {\"term_id\": \"R-HSA-9748784\", \"supporting_discovery_ids\": [13, 14, 15]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [6, 10]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"EZR\", \"GP78\", \"PDZK1\", \"hnRNPA2B1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}